Navigating Diabetes

  • Location

    Zoom-US

  • Phone

    +966 112790305

  • Website: www.credit-hours.com Join Event
  • Email Address: info@credit-hours.com
  • Email Activity Coordinator: cpd2@credit-hours.com
  • Phone Activity Coordinator: +966 598987505

Event Audience

  • Cardiovascular Technology
  • Echocardiography Technology
  • Cardiac Catheterization Technology
  • Echocardiography
  • Family Medicine
  • General surgery
  • Internal Medicine
  • Emergency Medicine
  • Vascular Surgery
  • General Practice
  • Thoracic and Cardiac Surgery
  • Cardiac Surgery
  • Critical Care Medicine
  • Allergy and Immumology
  • Cardiology
  • Pulmonology
  • Public Health
  • Geriatric Medicine
  • Thoracic Surgery
  • Nephrology
  • Endocrinology
  • Vascular and Endovascular Surgery
  • Renal transplant
  • Preventive Medicine
  • Family and Community Medicine
  • Midwifery
  • Nursing
  • Adult Critical Care Nursing
  • Primary Health Care Nursing
  • Psychological and Mental Health Nursing
  • Nursing Education
  • Cardiovascular Nursing
  • Geriatric Nursing
  • Diabetic Care Nursing
  • Community and Public Health Nursing
  • Disaster and Emergency Nursing
  • Emergency and Disaster Nursing Administration
  • Pharmaceutical Sciences
  • Clinical Pharmacy
  • Pharmaceutical administration AND outcomes
  • Pharmacy

Event Goals

  • • Interpret the latest updated guidelines and recommendations concerning the diagnosis, new emerging therapeutic agents that are indicated for the treatment and management of CRM
  • • Analyse the clinical outcomes associated with the use of emerging therapies in patients with CRM diseases, focusing on improvements in cardiovascular, renal, and metabolic health.
  • • Assess the benefits and limitations of SGLT2 inhibitors in the treatment of patients with coexisting cardiovascular, renal, and metabolic diseases, focusing on their role in heart failure, hypertension, and kidney protection
  • • Explain how chronic kidney disease (CKD), heart failure (HF), atherosclerotic cardiovascular disease (ASCVD), and type 2 diabetes (T2D) are interrelated and their combined impact on disease progression and clinical outcomes.
  • • Illustrate the role of new therapeutic agents in targeting multiple aspects of CRM syndrome.
  • • Define the benefits of telemedicine in the management of Diabetes associated with other comorbidities
  • • Implement new strategies for the treatment and management of Diabetes focusing on improvements in cardiovascular, renal, and metabolic health specially special patients as elderly patients

Event Agenda

21/04/2025

Welcome and Introduction

19:45:00 - 19:55:00
Speaker(s): No speakers assigned
21/04/2025

Pre-test to assess the current knowledge

20:00:00 - 20:10:00
Speaker(s): خالد ابن زكي الشالى (KHALID ZAKI ALSHALI)
21/04/2025

how can telemedicine be utilized in diabetes care ?

20:15:00 - 20:45:00
Speaker(s): محمد بن شطرين ال مهذل (MOHAMMED SHATREIN ALMEHTHEL)
21/04/2025

how can diabetes be managed in elderly patients?

21:00:00 - 21:30:00
Speaker(s): محمد بن شطرين ال مهذل (MOHAMMED SHATREIN ALMEHTHEL)
21/04/2025

cardio-renal metabolic interconnectivity

21:40:00 - 22:40:00
Speaker(s): خالد ابن زكي الشالى (KHALID ZAKI ALSHALI)
21/04/2025

Case-based Discussion and Q/A session

22:50:00 - 23:20:00
Speaker(s): خالد ابن زكي الشالى (KHALID ZAKI ALSHALI) , محمد بن شطرين ال مهذل (MOHAMMED SHATREIN ALMEHTHEL)
21/04/2025

Post-Test

23:25:00 - 23:35:00
Speaker(s): خالد ابن زكي الشالى (KHALID ZAKI ALSHALI)
21/04/2025

Take home messages and Closure

23:40:00 - 23:50:00
Speaker(s): No speakers assigned